Fourth Wall Theatrical Limited
Unaudited Financial Statements
For the period ended 31 December 2023
Pages for Filing with Registrar
Company Registration No. 14119049 (England and Wales)
Fourth Wall Theatrical Limited
Contents
Page
Balance sheet
1
Notes to the financial statements
2 - 4
Fourth Wall Theatrical Limited
Balance Sheet
As at 31 December 2023
Page 1
2023
2023
Notes
£
£
£
£
Current assets
Investments
3
-
0
77,500
Cash at bank and in hand
24,222
18,372
24,222
95,872
Creditors: amounts falling due within one year
4
(98,480)
(98,552)
Net current liabilities
(74,258)
(2,680)
Capital and reserves
Called up share capital
5
100
100
Profit and loss reserves
(74,358)
(2,780)
Total equity
(74,258)
(2,680)

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial period ended 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 24 September 2024
J Bezdek
Director
Company Registration No. 14119049
Fourth Wall Theatrical Limited
Notes to the Financial Statements
For the period ended 31 December 2023
Page 2
1
Accounting policies
Company information

Fourth Wall Theatrical Limited is a private company limited by shares incorporated in England and Wales. The registered office is c/o 6th Floor Charlotte Building, 17 Gresse Street, London, United Kingdom, W1T 1QL.

1.1
Reporting period

The company's financial statements are presented for the 7 month period ended 31 December 2023. The comparative figures relate to the period from incorporation on 19 May 2022 to 31 May 2023.

1.2
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.3
Going concern

The company is supported by a loan from its parent entity. The parent entity has confirmed that it will not require repayment of this loan within a period of 12 months from the date of signature of these accounts unless the company is able to do so without preventing it from meeting its other liabilities as they fall due or preventing it from continuing to trade.true

 

On that basis and at the time of approving the financial statements, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.4
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business and represents fees and profit distributions from theatrical productions.

 

Distributions from theatrical productions are recognised once they can be reliably determined, usually once a statement has been received from a third party. This is consistent with industry practice.

1.5
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Fourth Wall Theatrical Limited
Notes to the Financial Statements (Continued)
For the period ended 31 December 2023
1
Accounting policies
(Continued)
Page 3
1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

 

Current asset investments are investments in theatrical productions which take the form of non-recourse loans advanced to the productions which are repayable out of the profits of the productions. These investments are initially measured at fair value which is normally the transaction price. In general fair values subsequent to the initial investment cannot be measured reliably so investments in theatrical productions are subsequently measured at cost less impairment.

 

The company reviews the carrying value amounts of its investments at each reporting period end date to

determine whether there is any indication that those investments have suffered an impairment loss. If any such indication exists, the recoverable amount of the investment is estimated in order to determine the extent of the impairment loss (if any). Recoverable amount is the higher of fair value less costs to sell and value in use and in practice will generally equate to the amount of the loan which is expected to be repaid by the production.

 

Impairment losses are recognised immediately in profit or loss. Recognised impairment losses arereversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses the carrying amount of the ivestment is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset. A reversal of the impairment loss is recognised immediately in profit or loss.

 

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

Fourth Wall Theatrical Limited
Notes to the Financial Statements (Continued)
For the period ended 31 December 2023
Page 4
2
Employees

The average monthly number of persons (including directors) employed by the company during the period was:

2023
2023
Number
Number
Total
1
1
3
Current asset investments
2023
2023
£
£
Other investments
-
0
77,500
4
Creditors: amounts falling due within one year
2023
2023
£
£
Amounts owed to group undertakings
94,040
96,332
Accruals and deferred income
4,440
2,220
98,480
98,552
5
Called up share capital
2023
2023
2023
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
100
100
100
100

On incorporation 100 £1 ordinary shares were issued for cash at par.

2023-12-312023-06-01false25 September 2024CCH SoftwareCCH Accounts Production 2024.210No description of principal activityJ Bezdekfalsefalse141190492023-06-012023-12-31141190492023-12-31141190492023-05-3114119049core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3114119049core:CurrentFinancialInstrumentscore:WithinOneYear2023-05-3114119049core:ShareCapital2023-12-3114119049core:ShareCapital2023-05-3114119049core:RetainedEarningsAccumulatedLosses2023-12-3114119049core:RetainedEarningsAccumulatedLosses2023-05-3114119049bus:Director12023-06-012023-12-31141190492022-05-192023-05-3114119049core:CurrentFinancialInstruments2023-12-3114119049core:CurrentFinancialInstruments2023-05-3114119049bus:PrivateLimitedCompanyLtd2023-06-012023-12-3114119049bus:SmallCompaniesRegimeForAccounts2023-06-012023-12-3114119049bus:FRS1022023-06-012023-12-3114119049bus:AuditExemptWithAccountantsReport2023-06-012023-12-3114119049bus:FullAccounts2023-06-012023-12-31xbrli:purexbrli:sharesiso4217:GBP